These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 27913060)

  • 21. Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-alpha therapy.
    Roux CH; Brocq O; Breuil V; Albert C; Euller-Ziegler L
    Rheumatology (Oxford); 2007 Apr; 46(4):695-8. PubMed ID: 17158212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug insight: Anti-tumor necrosis factor therapy for inflammatory arthropathies during reproduction, pregnancy and lactation.
    Skomsvoll JF; Wallenius M; Koksvik HS; Rødevand E; Salvesen KA; Spigset O; Kvien TK
    Nat Clin Pract Rheumatol; 2007 Mar; 3(3):156-64. PubMed ID: 17334338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.
    Deepak P; Sifuentes H; Sherid M; Stobaugh D; Sadozai Y; Ehrenpreis ED
    Am J Gastroenterol; 2013 Jan; 108(1):99-105. PubMed ID: 23032984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of co-existing immune-mediated diseases on phenotype and outcomes in inflammatory bowel diseases.
    Conway G; Velonias G; Andrews E; Garber JJ; Yajnik V; Ananthakrishnan AN
    Aliment Pharmacol Ther; 2017 Mar; 45(6):814-823. PubMed ID: 28105709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preterm birth in women with inflammatory bowel disease - the association with disease activity and drug treatment.
    Bröms G; Granath F; Stephansson O; Kieler H
    Scand J Gastroenterol; 2016 Dec; 51(12):1462-1469. PubMed ID: 27739352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity of monoclonal antibodies against tumor necrosis factor used in chronic immune-mediated Inflammatory conditions: systematic review and meta-analysis.
    Maneiro JR; Salgado E; Gomez-Reino JJ
    JAMA Intern Med; 2013 Aug; 173(15):1416-28. PubMed ID: 23797343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study.
    Moens A; van der Woude CJ; Julsgaard M; Humblet E; Sheridan J; Baumgart DC; Gilletta De Saint-Joseph C; Nancey S; Rahier JF; Bossuyt P; Cremer A; Dewit S; Eriksson C; Hoentjen F; Krause T; Louis E; Macken E; Milenkovic Z; Nijs J; Posen A; Van Hootegem A; Van Moerkercke W; Vermeire S; Bar-Gil Shitrit A; Ferrante M
    Aliment Pharmacol Ther; 2020 Jan; 51(1):129-138. PubMed ID: 31692017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Risk of Adverse Neonatal Outcomes With Maternal Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Leung KK; Tandon P; Govardhanam V; Maxwell C; Huang V
    Inflamm Bowel Dis; 2021 Mar; 27(4):550-562. PubMed ID: 32469057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paediatric infections in the first 3 years of life after maternal anti-TNF treatment during pregnancy.
    Bröms G; Kieler H; Ekbom A; Gissler M; Hellgren K; Leinonen MK; Pedersen L; Schmitt-Egenolf M; Sørensen HT; Granath F
    Aliment Pharmacol Ther; 2020 Sep; 52(5):843-854. PubMed ID: 32706178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth Outcomes.
    Julsgaard M; Hvas CL; Gearry RB; Gibson PR; Fallingborg J; Sparrow MP; Bibby BM; Connell WR; Brown SJ; Kamm MA; Lawrance IC; Vestergaard T; Svenningsen L; Baekdal M; Kammerlander H; Walsh A; Boysen T; Bampton P; Radford-Smith G; Kjeldsen J; Andrews JM; Subramaniam K; Moore GT; Jensen NM; Connor SJ; Wildt S; Wilson B; Ellard K; Christensen LA; Bell SJ
    Inflamm Bowel Dis; 2020 Jan; 26(1):93-102. PubMed ID: 31141607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety of Anti-TNF-Alpha Therapy During Pregnancy on Long-term Outcome of Exposed Children: A Controlled, Multicenter Observation.
    Duricova D; Dvorakova E; Hradsky O; Mitrova K; Durilova M; Kozeluhova J; Kohout P; Zarubova K; Bronsky J; Hradska N; Bronska E; Adamcova M; Machkova N; Hruba V; Bortlik M; Lukas M; Malickova K; Lukas M
    Inflamm Bowel Dis; 2019 Mar; 25(4):789-796. PubMed ID: 30239799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and economic burden of extra-articular manifestations in ankylosing spondylitis patients treated with anti-tumor necrosis factor agents.
    Gao X; Wendling D; Botteman MF; Carter JA; Rao S; Cifaldi M
    J Med Econ; 2012; 15(6):1054-63. PubMed ID: 22563743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy.
    Schnitzler F; Fidder H; Ferrante M; Ballet V; Noman M; Van Assche G; Spitz B; Hoffman I; Van Steen K; Vermeire S; Rutgeerts P
    Inflamm Bowel Dis; 2011 Sep; 17(9):1846-54. PubMed ID: 21830263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel disease.
    Seirafi M; de Vroey B; Amiot A; Seksik P; Roblin X; Allez M; Peyrin-Biroulet L; Marteau P; Cadiot G; Laharie D; Boureille A; De Vos M; Savoye G; Rahier JF; Carbonnel F; Bonaz B; Colombel JF; Bouhnik Y
    Aliment Pharmacol Ther; 2014 Aug; 40(4):363-73. PubMed ID: 24980270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neonatal Outcomes in Women With Untreated Antenatal Depression Compared With Women Without Depression: A Systematic Review and Meta-analysis.
    Jarde A; Morais M; Kingston D; Giallo R; MacQueen GM; Giglia L; Beyene J; Wang Y; McDonald SD
    JAMA Psychiatry; 2016 Aug; 73(8):826-37. PubMed ID: 27276520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Birth Outcomes in Children Fathered by Men Treated with Anti-TNF-α Agents Before Conception.
    Larsen MD; Friedman S; Magnussen B; Nørgård BM
    Am J Gastroenterol; 2016 Nov; 111(11):1608-1613. PubMed ID: 27619836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative effectiveness of abatacept, apremilast, secukinumab and ustekinumab treatment of psoriatic arthritis: a systematic review and network meta-analysis.
    Kawalec P; Holko P; Moćko P; Pilc A
    Rheumatol Int; 2018 Feb; 38(2):189-201. PubMed ID: 29285605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do tumor necrosis factor inhibitors increase cancer risk in patients with chronic immune-mediated inflammatory disorders?
    Chen Y; Friedman M; Liu G; Deodhar A; Chu CQ
    Cytokine; 2018 Jan; 101():78-88. PubMed ID: 27688201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.
    Bongartz T; Sutton AJ; Sweeting MJ; Buchan I; Matteson EL; Montori V
    JAMA; 2006 May; 295(19):2275-85. PubMed ID: 16705109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.